BCM
QGENF

BlueCrest Capital Management’s QIAGEN NV QGENF Stock Holding History

BlueCrest Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,263
Closed -$1.1M – 1051
2016
Q4 		$1.1M Buy
+39,263
New +$1.1M 0.06% 351
2016
Q2 		– Sell
-82,531
Closed -$1.84M – 1195
2016
Q1 		$1.84M Buy
82,531
+64,828
+366% +$1.45M 0.11% 252
2015
Q4 		$489K Buy
+17,703
New +$489K 0.02% 590
2015
Q2 		– Sell
-156,750
Closed -$3.95M – 1057
2015
Q1 		$3.95M Buy
156,750
+132,930
+558% +$3.35M 0.21% 141
2014
Q4 		$559K Buy
+23,820
New +$559K 0.02% 438

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

BlueCrest Capital Management's QGENF Position: Q1 2017 in Review

BlueCrest Capital Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 39,263 shares — an estimated $1.1M sold.

BlueCrest Capital Management first reported a position in QGENF in Q4 2014 and held it in 5 quarters. The position peaked at $3.95M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • BlueCrest Capital Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • BlueCrest Capital Management sold 39,263 QIAGEN NV shares in Q1 2017, an estimated $1.1M.
  • BlueCrest Capital Management first reported a position in QIAGEN NV in Q4 2014 and held it in 5 quarters.
  • BlueCrest Capital Management's QIAGEN NV position peaked at $3.95M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on BlueCrest Capital Management's 13F filing for Q1 2017, filed 15 May 2017.